Stock 1877 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Junshi Biosciences Co., Ltd.

Equities

1877

CNE100003FF7

Delayed Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
11.76 HKD +8.49% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. +26.59% -39.51%
Apr. 29 Shanghai Junshi Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Shanghai Junshi Biosciences Receives Hong Kong Approval for Cancer Drug Toripalimab MT

Evolution of the average Target Price on Shanghai Junshi Biosciences Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

8a4c9aef136c97f.Lg50Hz-ExS6XGUTyDGxZ7Eb7PdBMihBcMBDYLwWJ7LY.Z0EELW3hl2XhKim-ZBg1thGpVKk_2ENoVCioelC53MR3fhtFDPGHRNYsEQ~3106d5c53ed816c1487261e0361d343d

Analyst Recommendations on Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences' 2022 Loss Widens, Misses Analysts' Expectations MT
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy MT
UBS Adjusts Shanghai Junshi Biosciences’ Price Target to HK$70.90 From HK$77.70, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
10.88 CNY
Average target price
22.5 CNY
Spread / Average Target
+106.75%
High Price Target
42.1 CNY
Spread / Highest target
+286.80%
Low Price Target
9.239 CNY
Spread / Lowest Target
-15.11%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shanghai Junshi Biosciences Co., Ltd.

UBS

Ratings for Shanghai Junshi Biosciences Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. Consensus Shanghai Junshi Biosciences Co., Ltd.